Purchased Product
Fluorescent DOTAP (CAS 1010076-97-7), a cationic lipid labeled with a fluorescent marker for easy tracking and analysis.
Application
The laboratory formulated liposomes using Fluorescent DOTAP to encapsulate a combination of hydrophobic chemotherapy drugs and hydrophilic small molecule inhibitors. The cationic lipids' positive charge enabled effective interaction with the negatively charged cell membranes, leading to enhanced cellular uptake. The fluorescent labeling of DOTAP allowed the team to track the liposomal formulations in real-time using fluorescence microscopy. In vitro studies on cancer cell lines showed increased drug accumulation inside the cells, while in vivo studies confirmed targeted drug release at the tumor site, minimizing systemic side effects. The liposomes demonstrated a 40% increase in therapeutic efficacy compared to free drug administration.
Client Feedback
"Using Fluorescent DOTAP in our drug delivery systems has been a game-changer. The fluorescent labeling allowed us to precisely monitor the liposomes' behavior inside cells, providing us with invaluable data. This lipid's performance has exceeded our expectations, and we're excited to continue using it in our research."